Karachi: Citi Pharma Ltd. has disclosed a recent transaction involving the acquisition of shares by its Executive Director, Rizwan Ahmad. The announcement, dated January 21, 2026, details the purchase of shares as part of the required disclosure under the Pakistan Stock Exchange (PSX) Regulation 5.6.4.

According to the disclosure, Rizwan Ahmad executed a transaction on January 20, 2026, to buy 755,000 shares of Citi Pharma Ltd. The purchase was conducted in the ready market segment, utilizing the Central Depository Company (CDC) as the form of share certificate.

The acquisition has resulted in a cumulative holding of 21.23% in the company by Mr. Ahmad. The exact rate at which the shares were acquired was not specified in the document provided.

According to information available from the Pakistan Stock Exchange (PSX), transactions of this nature are part of routine disclosures that inform stakeholders about changes in shareholding by key company figures.

This development indicates a strategic move by the Executive Director to increase his stake in the company, aligning with the broader market category that includes healthcare and pharmaceutical sectors. The cumulative percentage now held by Mr. Ahmad reflects his growing influence within the company.